Skip to content

Clinical observation on the anti wrinkle safety and efficacy of SILAB yeast extract

Clinical observation on the anti wrinkle safety and efficacy of SILAB yeast extract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082824
Enrollment
Unknown
Registered
2024-04-09
Start date
2023-11-08
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wrinkle

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Healthy women aged 55 and above 2. Dry skin (test value<40) 3. Changes in facial skin matrix 4. Dark skin 5. Willing to use designated test products as instructed during the research period, and will not use any new facial products other than the designated test products 6. Project informed consent and signing of project informed consent form 7. Willing to comply with the test requirements and complete the entire test for a total of 56 days 8. Able to complete follow-up as required

Exclusion criteria

Exclusion criteria: 1. Planned pregnancy or pregnant, lactating women 2. Have allergic diseases and a history of allergies to cosmetics, skincare products, and other topical preparations 3. Skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.), or obvious wounds, abrasions, tattoos, scars, pigmentation, atrophy, bright red stains, or other defects in or near the test area 4. Have undergone skin care (exfoliation, facial scrub, blackening, whitening, anti wrinkle, etc.) within one month prior to the start of the study 5. Experts or professionals believe that there are other iatrogenic reasons that may affect the test results 6. Participants in other clinical trials 7. Non voluntary participants or those who cannot complete the required content according to the experimental requirements

Design outcomes

Primary

MeasureTime frame
wrinkle;Dermal density;Skin moisture content ;Skin glossiness;Safety assessment;

Countries

China

Contacts

Public ContactWang Xi

West China Hospital, Sichuan University

xierwang@126.com+86 28 8542 2075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026